High Tumor Mutation Burden
1 clinical trials · Condition
◉ Watch High Tumor Mutation Burden
| Record | Firm | Date |
|---|---|---|
| Study of MK-3475 (Pembrolizumab) in Patients With Microsatellite Unstable (MSI) Tumors (Cohort D) (NCT04098068) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-01-25 |
Track High Tumor Mutation Burden automatically
Every clearance here is in the API, with alerts when new ones post.